Comparative Pharmacology
Head-to-head clinical analysis: CODEINE ASPIRIN APAP FORMULA NO 2 versus METHADOSE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CODEINE ASPIRIN APAP FORMULA NO 2 versus METHADOSE.
CODEINE, ASPIRIN, APAP FORMULA NO. 2 vs METHADOSE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Codeine is a prodrug that is metabolized to morphine, which acts as an agonist at mu-opioid receptors in the central nervous system, producing analgesia. Aspirin irreversibly inhibits cyclooxygenase-1 and -2, reducing prostaglandin synthesis and providing analgesic, anti-inflammatory, and antipyretic effects. Acetaminophen (APAP) inhibits cyclooxygenase centrally, with weak peripheral activity, producing analgesia and antipyresis.
Methadone is a mu-opioid receptor agonist; it also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake, contributing to its analgesic and detoxification effects. It has a long half-life and reduces opioid craving and withdrawal symptoms.
1 to 2 tablets orally every 4 to 6 hours as needed for pain; maximum 12 tablets per day. Each tablet contains codeine 30 mg, aspirin 325 mg, and acetaminophen 325 mg.
Oral: 20-40 mg once daily, titrated to effect; for opioid dependence, typical maintenance 80-120 mg/day. IV: 2.5-10 mg every 8-12 hours.
None Documented
None Documented
Codeine: 2.5-4 hours. Aspirin (as salicylate): 2-3 hours (low dose), up to 15-30 hours (high dose due to saturable metabolism). Acetaminophen: 2-3 hours (therapeutic doses), prolonged in overdose or hepatic impairment.
Terminal elimination half-life range: 8–59 hours (mean ~20–35 hours). In chronic use, half-life may increase due to accumulation. Context: The long half-life supports once-daily dosing for opioid dependence but requires careful titration to avoid accumulation.
Codeine: Renal 90% (10% unchanged, 80% as conjugates). Aspirin: Renal 80-100% (dose-dependent, as salicylate and metabolites). Acetaminophen (APAP): Predominantly renal (90-100% as conjugates, <5% unchanged).
Primarily renal (approximately 80%) as inactive metabolites, with about 20% eliminated via feces. Less than 10% excreted unchanged.
Category D/X
Category C
Opioid Agonist
Opioid Agonist